Additional Years of Secondary Schooling Can Cut HIV Risk

This article originally appeared here.
Share this content:
Additional Years of Secondary Schooling Can Cut HIV Risk
Additional Years of Secondary Schooling Can Cut HIV Risk

THURSDAY, July 2, 2015 (HealthDay News) -- Additional years of secondary schooling provide a cost-effective HIV prevention measure in Botswana, according to a study published online June 28 in The Lancet Global Health.

Jan-Walter De Neve, M.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues obtained data for HIV biomarkers and demographics from the nationally representative household Botswana AIDS Impact Surveys from 2004 to 2008 (7,018 participants). Botswana reformed the grade structure of secondary school in 1996, expanding access to grade 10 and increasing educational attainment. The causal effect of years of schooling was assessed on the cumulative probability that an individual contracted HIV up to their age at the time of the survey. The authors also examined the cost-effectiveness of secondary schooling as an HIV prevention intervention.

The researchers found that with each additional year of secondary schooling there was an absolute reduction in the cumulative risk of HIV infection (8.1 percent; P = 0.008), relative to a baseline prevalence of 25.5 percent in the pre-reform birth cohort. In women, the effect was particularly large (11.6 percent; P = 0.046). By standard metrics, secondary school was cost-effective as an HIV prevention intervention (cost per HIV infection averted, $27,753).

"Increasing progression through secondary school could be a cost-effective HIV prevention measure in HIV-endemic settings, in addition to yielding other societal benefits," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »